| Genotype, N (%) | Comm-contl | MDD | Comm-suic |  |  | ||||
---|---|---|---|---|---|---|---|---|---|---|
Group | 3R-H | 4R-H | χ2 | P | χ2 | P | χ2 | P | OR | 95% C.I. |
Comm-contl | 199(64.82%) | 108(35.18%) | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 111(61.32%) | 70(38.68%) | Â | Â | Â | Â | Â | Â | Â | Â |
Female | 88(69.84%) | 38(30.16%) | Â | Â | Â | Â | Â | Â | Â | Â |
MDD | 153(57.74%) | 112(42.26%) | 3.016 | 0.082 | Â | Â | Â | Â | Â | Â |
Male | 72(50.00%) | 72(50.00%) | 4.182 | 0.041* | Â | Â | Â | Â | 1.586 | 1.019-2.467 |
Female | 81(66.94%) | 40(33.06%) | 0.240 | 0.624 | Â | Â | Â | Â | Â | Â |
Comm-suic | 30(60.00%) | 20(40.00%) | 0.434 | 0.510 | Â | Â | Â | Â | Â | Â |
Male | 19(55.88%) | 15(44.12%) | 0.355 | 0.551 | 0.381 | 0.537 | Â | Â | Â | Â |
Female | 11(68.75%) | 5(31.25%) | 0.008 | 0.929 | 0.021 | 0.885 | Â | Â | Â | Â |
MDD-suic | 46(60.53%) | 30(39.47%) | 0.487 | 0.485 | Â | Â | Â | Â | Â | Â |
Male | 22(50.00%) | 22(50.00%) | 1.879 | 0.170 | 0.000 | 1.000 | 0.266 | 0.606 | Â | Â |
Female | 24(75.00%) | 8(25.00%) | 0.329 | 0.566 | 0.763 | 0.382 | 0.211 | 0.646 | Â | Â |